Lack of effect of L-carnitine supplementation on weight gain in very preterm infants

Sumati Pande, Luc P. Brion, Deborah E. Campbell, Yvonne Gayle, Nora V. Esteban-Cruciani

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objective: Carnitine transfer across the placenta occurs predominantly during the third trimester. Unless L-carnitine is provided, very preterm infants develop carnitine deficiency. Although breast milk and infant formulas contain L-carnitine, parenteral nutrition solutions do not routinely provide L-carnitine. We hypothesized that prolonged L-carnitine supplementation in very preterm infants would improve weight gain and shorten length of stay in the hospital. Study design: The study was a double-blind parallel placebo-controlled randomized clinical trial. Eligible patients were <29 weeks of gestation, <72 hours of age, and did not have a potentially life-threatening congenital malformation or hereditary metabolic disorder. Patients were stratified by gestational age (23 to 256/7 and 26 to 286/7 weeks), and randomized to receive, either L-carnitine at a dose of 50 μmol/kg/day, or placebo. Carnitine was provided intravenously until the infants tolerated 16 ml/day of feeds. The sample size was calculated to have 80% power to detect a 10% increase in weight gain from birth until 36 weeks of postmenstrual age or discharge from the hospital. Secondary outcome variables included food efficiency (defined as weight gain divided by caloric intake), weight gain at 4 weeks of age, time to regain birth weight and length of stay. Results: Among the 63 infants enrolled in the trial, 32 were randomized to L-carnitine and 31 to placebo. L-Carnitine supplementation did not significantly affect average daily weight gain from birth until 36 weeks or hospital discharge, or any of the secondary outcome variables. Conclusion: Prolonged supplementation of L-carnitine did not improve long-term weight gain in very preterm infants.

Original languageEnglish (US)
Pages (from-to)470-477
Number of pages8
JournalJournal of Perinatology
Volume25
Issue number7
DOIs
StatePublished - Jul 2005

Fingerprint

Carnitine
Premature Infants
Weight Gain
Placebos
Length of Stay
Parenteral Nutrition Solutions
Parturition
Infant Formula
Third Pregnancy Trimester
Human Milk
Energy Intake
Birth Weight
Sample Size
Placenta
Gestational Age
Randomized Controlled Trials
Food

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health

Cite this

Lack of effect of L-carnitine supplementation on weight gain in very preterm infants. / Pande, Sumati; Brion, Luc P.; Campbell, Deborah E.; Gayle, Yvonne; Esteban-Cruciani, Nora V.

In: Journal of Perinatology, Vol. 25, No. 7, 07.2005, p. 470-477.

Research output: Contribution to journalArticle

Pande, Sumati ; Brion, Luc P. ; Campbell, Deborah E. ; Gayle, Yvonne ; Esteban-Cruciani, Nora V. / Lack of effect of L-carnitine supplementation on weight gain in very preterm infants. In: Journal of Perinatology. 2005 ; Vol. 25, No. 7. pp. 470-477.
@article{601a26e113b94ddd8d371b7f406fcc87,
title = "Lack of effect of L-carnitine supplementation on weight gain in very preterm infants",
abstract = "Objective: Carnitine transfer across the placenta occurs predominantly during the third trimester. Unless L-carnitine is provided, very preterm infants develop carnitine deficiency. Although breast milk and infant formulas contain L-carnitine, parenteral nutrition solutions do not routinely provide L-carnitine. We hypothesized that prolonged L-carnitine supplementation in very preterm infants would improve weight gain and shorten length of stay in the hospital. Study design: The study was a double-blind parallel placebo-controlled randomized clinical trial. Eligible patients were <29 weeks of gestation, <72 hours of age, and did not have a potentially life-threatening congenital malformation or hereditary metabolic disorder. Patients were stratified by gestational age (23 to 256/7 and 26 to 286/7 weeks), and randomized to receive, either L-carnitine at a dose of 50 μmol/kg/day, or placebo. Carnitine was provided intravenously until the infants tolerated 16 ml/day of feeds. The sample size was calculated to have 80{\%} power to detect a 10{\%} increase in weight gain from birth until 36 weeks of postmenstrual age or discharge from the hospital. Secondary outcome variables included food efficiency (defined as weight gain divided by caloric intake), weight gain at 4 weeks of age, time to regain birth weight and length of stay. Results: Among the 63 infants enrolled in the trial, 32 were randomized to L-carnitine and 31 to placebo. L-Carnitine supplementation did not significantly affect average daily weight gain from birth until 36 weeks or hospital discharge, or any of the secondary outcome variables. Conclusion: Prolonged supplementation of L-carnitine did not improve long-term weight gain in very preterm infants.",
author = "Sumati Pande and Brion, {Luc P.} and Campbell, {Deborah E.} and Yvonne Gayle and Esteban-Cruciani, {Nora V.}",
year = "2005",
month = "7",
doi = "10.1038/sj.jp.7211334",
language = "English (US)",
volume = "25",
pages = "470--477",
journal = "Journal of Perinatology",
issn = "0743-8346",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Lack of effect of L-carnitine supplementation on weight gain in very preterm infants

AU - Pande, Sumati

AU - Brion, Luc P.

AU - Campbell, Deborah E.

AU - Gayle, Yvonne

AU - Esteban-Cruciani, Nora V.

PY - 2005/7

Y1 - 2005/7

N2 - Objective: Carnitine transfer across the placenta occurs predominantly during the third trimester. Unless L-carnitine is provided, very preterm infants develop carnitine deficiency. Although breast milk and infant formulas contain L-carnitine, parenteral nutrition solutions do not routinely provide L-carnitine. We hypothesized that prolonged L-carnitine supplementation in very preterm infants would improve weight gain and shorten length of stay in the hospital. Study design: The study was a double-blind parallel placebo-controlled randomized clinical trial. Eligible patients were <29 weeks of gestation, <72 hours of age, and did not have a potentially life-threatening congenital malformation or hereditary metabolic disorder. Patients were stratified by gestational age (23 to 256/7 and 26 to 286/7 weeks), and randomized to receive, either L-carnitine at a dose of 50 μmol/kg/day, or placebo. Carnitine was provided intravenously until the infants tolerated 16 ml/day of feeds. The sample size was calculated to have 80% power to detect a 10% increase in weight gain from birth until 36 weeks of postmenstrual age or discharge from the hospital. Secondary outcome variables included food efficiency (defined as weight gain divided by caloric intake), weight gain at 4 weeks of age, time to regain birth weight and length of stay. Results: Among the 63 infants enrolled in the trial, 32 were randomized to L-carnitine and 31 to placebo. L-Carnitine supplementation did not significantly affect average daily weight gain from birth until 36 weeks or hospital discharge, or any of the secondary outcome variables. Conclusion: Prolonged supplementation of L-carnitine did not improve long-term weight gain in very preterm infants.

AB - Objective: Carnitine transfer across the placenta occurs predominantly during the third trimester. Unless L-carnitine is provided, very preterm infants develop carnitine deficiency. Although breast milk and infant formulas contain L-carnitine, parenteral nutrition solutions do not routinely provide L-carnitine. We hypothesized that prolonged L-carnitine supplementation in very preterm infants would improve weight gain and shorten length of stay in the hospital. Study design: The study was a double-blind parallel placebo-controlled randomized clinical trial. Eligible patients were <29 weeks of gestation, <72 hours of age, and did not have a potentially life-threatening congenital malformation or hereditary metabolic disorder. Patients were stratified by gestational age (23 to 256/7 and 26 to 286/7 weeks), and randomized to receive, either L-carnitine at a dose of 50 μmol/kg/day, or placebo. Carnitine was provided intravenously until the infants tolerated 16 ml/day of feeds. The sample size was calculated to have 80% power to detect a 10% increase in weight gain from birth until 36 weeks of postmenstrual age or discharge from the hospital. Secondary outcome variables included food efficiency (defined as weight gain divided by caloric intake), weight gain at 4 weeks of age, time to regain birth weight and length of stay. Results: Among the 63 infants enrolled in the trial, 32 were randomized to L-carnitine and 31 to placebo. L-Carnitine supplementation did not significantly affect average daily weight gain from birth until 36 weeks or hospital discharge, or any of the secondary outcome variables. Conclusion: Prolonged supplementation of L-carnitine did not improve long-term weight gain in very preterm infants.

UR - http://www.scopus.com/inward/record.url?scp=22144499567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22144499567&partnerID=8YFLogxK

U2 - 10.1038/sj.jp.7211334

DO - 10.1038/sj.jp.7211334

M3 - Article

VL - 25

SP - 470

EP - 477

JO - Journal of Perinatology

JF - Journal of Perinatology

SN - 0743-8346

IS - 7

ER -